Concepedia

Publication | Open Access

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

DOIFull Paper Access

55

Citations

13

References

2018

Year

Kazuhiro Araki, Yoshinori Ito, Ippei Fukada, Kokoro Kobayashi, Yoshimasa Miyagawa, Michiko Imamura, Ayako Kira, Yuichi Takatsuka, Chiyomi Egawa, Hirofumi Suwa,
BMC Cancer

Abstract

UMIN000012375 , registration date: 21NOV2013, and UMIN000006838 , registration date: 6DEC2011.

References

YearCitations

Page 1